"Hyaluronic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A natural high-viscosity mucopolysaccharide with alternating beta (1-3) glucuronide and beta (1-4) glucosaminidic bonds. It is found in the UMBILICAL CORD, in VITREOUS BODY and in SYNOVIAL FLUID. A high urinary level is found in PROGERIA.
Descriptor ID |
D006820
|
MeSH Number(s) |
D09.698.373.475
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hyaluronic Acid".
Below are MeSH descriptors whose meaning is more specific than "Hyaluronic Acid".
This graph shows the total number of publications written about "Hyaluronic Acid" by people in this website by year, and whether "Hyaluronic Acid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 0 | 1 | 1 |
2007 | 0 | 1 | 1 |
2008 | 0 | 1 | 1 |
2015 | 0 | 1 | 1 |
2016 | 2 | 0 | 2 |
2017 | 12 | 7 | 19 |
2018 | 13 | 7 | 20 |
2019 | 5 | 4 | 9 |
2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hyaluronic Acid" by people in Profiles.
-
COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction. JCI Insight. 2021 09 08; 6(17).
-
Inhalable nanocatchers for SARS-CoV-2 inhibition. Proc Natl Acad Sci U S A. 2021 07 20; 118(29).
-
Hyaluronic acid soft tissue filler delayed inflammatory reaction following COVID-19 vaccination - A case report. J Cosmet Dermatol. 2021 Sep; 20(9):2684-2690.
-
Chitosan, alginate, hyaluronic acid, gums, and ß-glucan as potent adjuvants and vaccine delivery systems for viral threats including SARS-CoV-2: A review. Int J Biol Macromol. 2021 Jul 01; 182:1931-1940.
-
Good tolerance of hyaluronic acid injections during the period of the COVID-19 pandemic: observing a cohort of 1093 patients in a prospective, observational real-life study. J Eur Acad Dermatol Venereol. 2021 Jul; 35(7):e432-e433.
-
Hypersensitivity reaction to Hyaluronic Acid Dermal filler following novel Coronavirus infection - a case report. J Cosmet Dermatol. 2021 May; 20(5):1557-1562.
-
Delayed hypersensitivity reaction to hyaluronic acid dermal filler post-COVID-19 viral infection. J Cosmet Dermatol. 2021 May; 20(5):1549-1550.
-
"COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment". Arch Dermatol Res. 2022 Jan; 314(1):1-15.
-
Tackling osteoarthritis during COVID-19 pandemic. Ann Rheum Dis. 2021 02; 80(2):151-153.
-
Presence of hyaluronan in lung alveoli in severe Covid-19: An opening for new treatment options? J Biol Chem. 2020 11 06; 295(45):15418-15422.